uuxn: 3935(:036- -93£4 4A23- A5D3- 4AD7BDZSC4FC
-x WE-A I-91A- PR Md

Ill||||||||IlllllllllllllllllllllllllllllllllllllllllllllllllllllllEd
HHMWHNHWHHWHHW
“mmmmﬂmmmmmmmumunmmmum

Accﬁ
”bras; " ' RESULTED Collect D/T:
SURGICAL PATHOL
Modifiers: (1 of 1)
Surgical Pathology Report
LE2J>-(3\:3
' . GWW (La/Mg Maxi
Specimen(s) Received C11ké$~t£hnu§> thgl [63
Left testicle

Clinical History Wﬁum w ML 0‘0‘65/3
Not stated. .
' I 54b: 69 M 4 1.72.01

()4; slew/LI
Gross Description

Left testicle: Received in formalin and consists of a testis
weighing 150 grams with attached spermatic cord. The spermatic cord
measures 9 cm in length and 1.5 cm in diameter and the testicle
measures 7.5 x 7 x 4 cm. The outer surface of the testis is inked
black. The specimen is bivalved to reveal a variegated cut surface
with multiple cysts and hemorrhage with the mass measuring 7 x 7 x 4
cm. The tumor does not invade the tunica albuginea. Representative
sections are taken as follows.

spermatic cord margin

mid spermatic cord

spermatic cord near testicle
tumor to normal testis

tumor to Spermatic cord

—8 tumor to outer surface of testis

oommpwal-J

Date of Dictation:

Gross Description By:

Microscopic Description
Performed.

Final Pathologic Diagnosis

 

LSURGICAL FATE!" "WWW" "WM" "

Acct#:

Page 2

.

(Continued)

 

Left testicle:

-Mixed malignant germ cell tumor, 7 cm.

-Tumor predominant by immature teratoma

—Focal embryonal carcinoma (<5%) and yolk sac tumor (<10%)
—The tumor is limited to the testis and tunica albuginea.
-The spermatic cord is not involved and margin is negative.

'—Lymphovascular invasion is not present.

-Remaining testicular tissue shows atrophy.

Pathologic Tumor Stage: pTlNXMX (Stage: IS)

Attending Pathologist:

***Electronically Signed Out By ‘ , ***

‘ Patient Name:

Case #:

Med. Rec. #:
Location:

Date Collected:

[9 “T35 db amaupzaa7'59hu

M U 'I‘I' 70%

   

 

mains-ms Olin-pans, 1’ 4 II?

Frimary Tumor Site DImrepancy
.M msuep-ncy ‘
W Malian-my Hlsmy ‘
Dual/Synchronous Primary Na d

 

 

 

 
   
 
   

 

 

 

 

 
 
   

/ Disaumn .

Reviewer laid-l - \Ev'm_"_
\ ate Reﬁned: 4 ”Aw“-

 

 

 

V4.00
TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

 

 

 

 

P
Case Quality Control Form completed for the submitted ca;

 

 

   

 

 

 

Tissue Source Site ('I‘SS): TSS Identiﬁer: J TSS Unique Patient identiﬁer: _
Com plated By (interviewer Name on OpenCIinica): ________Completed Date: -
lDiagnosls- Information . f . p. p i V' -1 3 ‘ I ' V I
# Data Element Entry Alternatives Working Instructions
(Predominantly) immature teratoma , Provide the diagnosis] histologic subtypefs) documented on
Pathvloaicmaeosis .m......1 Emilfili‘i”.?£§§‘iil§lii?f£{i§2":“WWf”
1 Prowded on Iowa! Yolk Sac Tumor <10,“ .9 -
Pathology Report
. . Provide the hlstologlc features selected on the TCGA Case
Histologic features of .
, Quah Control Form com leted forthls case.
2 the sample provxded Teratoma (Immature) 90% , W P
for TCGA, as reﬂected Embryonal Carcinoma 10%
on the CQCF.

 

 

 

(ms-cream sewer:someKarenina-reg? uahtyComrolFom

 

. Provide a reason describing why the diagnosis on the initial
the discrepancy hi$t°1°91C heterogeneity pathology report for this case is not consistent with the

between the pathology characteri st 1 c of mixed germ diagnosis selected on the TCGA Case Quality Control Form.
report and the TCGA cell tumors

Case Quality Control
Form.

3 Provide the reason for

 

Name of TSS Reviewing Provide the name of the pathologist who reviewed this case

4 Pathologist or for TCGA.
Biorepository Director

 

 

 

 

 

 

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled.

 

TSS Reviewing Pathologist or Biorepository Director Date I

I acknowledge that the above information provided by my institution Is true and correct and has been quality controlled Tlieiltrending Padiolagl'st or the
Department Chairman has been informed or is aware of the above discrepancy in diagnoses.

 

Principal Investigator Signature , Date

 

